ICMR's Proactive Approach to Health Enhancement

India Pharma Outlook Team | Tuesday, 20 February 2024

 India Pharma Outlook Team

The Indian Council of Medical Research (ICMR) recently announced a series of landmark guidelines and policies to strengthen health services in various regions. From improving early diagnosis and treatment of chronic diseases to combating infectious outbreaks, these initiatives demonstrate ICMR's commitment to improving public health outcomes worldwide.

The study of the ICMR on the strengthening of national non-communicable disease (NCD) programs on the early detection of breast cancer highlights the importance of breast screening as a tool for early diagnosis and treatment of suspected patients. I assure you, with breast cancer. By providing people with the knowledge and skills to make a difference, the program aims to increase survival rates and reduce the burden of breast cancer in India.

Recognizing the increasing prevalence of type 1 diabetes, ICMR has formulated comprehensive guidelines on various types of management of type 1 diabetes. This 12-chapter guide covers key areas of epidemiology, diagnosis, lifestyle modification, drug therapy, monitoring and problem management to improve patient care and type 1 diabetes.

ICMR has played an important role in shaping policy for tobacco control in India by developing the India Tobacco Control 2022 document. The council also contributed to creating a national tobacco control strategy, demonstrating its commitment to addressing issues that can prevent serious illness and death in the country.

For the prevention and control of snakebites, the ICMR-National Institute of Reproductive Health (NIRRCH) has submitted a roadmap for a national snakebite prevention and control program to Niti Ayog. This program aims to reduce the impact of snakebite disease and mortality through research-based strategies and policies.

The ICMRand multi-centre task force study on polycystic ovary syndrome (PCOS), the largest in India, provides important insights into PCOS's prevalence and regional variation. This data-driven approach provides valuable information for clinical management and policy-making related to PCO

© 2024 India Pharma Outlook. All Rights Reserved.